JasonHsuMD

Retinal Disease

Co-Director of Retina Research, The Retina Service of Wills Eye Hospital Associate Professor, Thomas Jefferson University Partner, Wills Eye Physicians-Mid Atlantic Retina

Join to view full profile

Dr. Hsu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hsu's full profile

Already have an account?

Office
840 Walnut St
Suite 1020
Philadelphia, PA 19107
Phone+1 800-331-6634

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Surgical Retina and Vitreous, 2005 - 2007
University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 2002 - 2005
Scripps Mercy HospitalInternship, Transitional Year, 2001 - 2002
Perelman School of Medicine at the University of PennsylvaniaClass of 2001

Certifications & Licensure

DE State Medical License 2007 - 2025
NJ State Medical License 2007 - 2025
PA State Medical License 2002 - 2024
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Achievement Award American Academy of Ophthalmology, 2017
Senior Honor Award American Society of Retina Specialists
Honor Award American Society of Retina Specialists
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments Start of enrollment: 2010 Nov 01
Completed
Not Applicable
Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy Start of enrollment: 2010 Feb 01
Completed
Not Applicable
Study Assessing Double-masked Uveitis Treatment Start of enrollment: 2011 May 01
Completed
Phase 3
A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye Start of enrollment: 2011 Aug 01
Unknown status
Not Applicable
23 Gauge and 20 Gauge Vitrectomy for Rhegmatogenous Retinal Detachments Start of enrollment: 2008 Apr 01
Completed
Not Applicable
The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble Start of enrollment: 2011 Jun 01
Completed
Not Applicable
Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment. Start of enrollment: 2013 Jun 01
Completed
Not Applicable
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy Start of enrollment: 2013 Aug 01
Terminated
Phase 3
Eplerenone for the Treatment of Central Serous Chorioretinopathy Start of enrollment: 2013 Oct 01
Completed
Not Applicable
Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. Start of enrollment: 2015 Feb 01
Completed
Phase 2
Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration Start of enrollment: 2017 Feb 08
Completed
Phase 2, Phase 3
Quality and Diagnostic Utility of Mydriatic Fundus Plenoptic Photography Start of enrollment: 2018 Dec 01
Withdrawn
A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR Start of enrollment: 2023 Feb 06
Recruiting
Phase 2, Phase 3
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Retinal Tear and Retinal Detachment after Cataract Surgery in Eyes with a Previous History of Treated Phakic Retinal Tears.
Bita Momenaei, Andrew Zhou, Adina S Kazan, Taku Wakabayashi, Anthony Obeid
Ophthalmology. 2024-12-01
Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection.
Asad F Durrani, Bita Momenaei, Viren Soni, Matthew Tennant, Jason Hsu
Journal of Ocular Pharmacology and Therapeutics. 2024-11-01
5 citations
Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.
Asad Farooq Durrani, Bita Momenaei, Taku Wakabayashi, Sudheshna Vemula, Saagar A Pandit
The British Journal of Ophthalmology. 2024-08-22

Press Mentions

Advice from the OR: RD and PVROctober 8th, 2024
Conducting Impactful Research as a Retina FellowMarch 2nd, 2023
CONTROVERSIES IN CARE: Chandelier-Assisted Scleral Buckle Surgery vs Traditional Scleral Buckle ProcedureJuly 1st, 2018
Join now to see all